Oliver Pohl's Colleagues at ObsEva SA
Delphine Renaud
Congress & Publications Manager / Commercialization Project Manager
Oliver Pohl's Contact Details
857-972-9364
ObsEva SA
Oliver Pohl's Company Details
Innovating Women's Reproductive Health and Pregnancy TherapeuticsObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV". For more information, please visit www.ObsEva.com.